Stanzen Life Sciences Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2018.
2018 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Stanzen Life Sciences Private Limited

Stanzen Life Sciences Private Limited, a active private limited company, was established on 21 September 2018 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299TG2018PTC127006. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Bhagavan Reddy Kamireddy (Director), Nitya Kamireddy (Director). Past directors included Osama Ashraf Abdul Hafeez. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7-102/36,Plot No-36,201, 2Nd Floor, Sai Srinivasa Residency,Habsiguda, Hyderabad, Telangana, 500007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299TG2018PTC127006

  • Registration Number

    127006

  • Incorporation Date

    21 September 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Profit Growth **** 83.33%
  • Ebitda **** 83.33%
  • Net Worth -25.00%
  • Total Assets **** %
Company report

Stanzen Life Sciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Stanzen Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Stanzen Life Sciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhagavan Reddy Kamireddy Director 21 Sep 2018 Current
Nitya Kamireddy Director 01 Jun 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Jun 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stanzen Life Sciences.

Stanzen Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 83.33% increase in profit. The company's net worth observed a substantial decline by a decrease of 25%.

Stanzen Life Sciences revenue growth over time
Stanzen Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
 83.33%
*******
*******
*******
*******
Net Worth
*******
 -25.00%
*******
*******
*******
*******
EBITDA
*******
 83.33%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stanzen Life Sciences?

In 2019, Stanzen Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Stanzen Life Sciences?

Unlock and access historical data on people associated with Stanzen Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stanzen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanzen Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stanzen Life Sciences
Recent Activity within the Organization
  • Annual General Meeting

    The activity Stanzen Life Sciences Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Stanzen Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Director Appointment

    The activity Nitya Kamireddy was appointed as a Director was appointed as a Director on 01 Jun 2023 & has been associated with this company since 2 years 9 months . was completed.

  • Director Appointment

    The activity Bhagavan Reddy Kamireddy was appointed as a Director was appointed as a Director on 21 Sep 2018 & has been associated with this company since 7 years 5 months . was completed.

  • Company Incorporation

    Stanzen Life Sciences Private Limited was registered on 21 Sep 2018 with Roc Hyderabad & aged 7 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Stanzen Life Sciences Private Limited?

The CIN of Stanzen Life Sciences Private Limited is U24299TG2018PTC127006.

Where is Stanzen Life Sciences Private Limited headquartered?

Stanzen Life Sciences Private Limited is headquartered at 7-102/36,Plot No-36,201, 2Nd Floor, Sai Srinivasa Residency,Habsiguda, Hyderabad, Telangana, 500007.

When was Stanzen Life Sciences Private Limited incorporated?

Stanzen Life Sciences Private Limited was incorporated on 21 September 2018.

Who are the current directors of Stanzen Life Sciences Private Limited?

The current directors of Stanzen Life Sciences Private Limited are

What is the primary industry of Stanzen Life Sciences Private Limited?

The primary industry of Stanzen Life Sciences Private Limited is Pharma.

Is Stanzen Life Sciences Private Limited a listed company?

Stanzen Life Sciences Private Limited is unlisted.

What is the capital structure of Stanzen Life Sciences Private Limited?

The authorized capital of Stanzen Life Sciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available